Investigating household access to malaria treatment Benjamin - - PowerPoint PPT Presentation

investigating household access
SMART_READER_LITE
LIVE PREVIEW

Investigating household access to malaria treatment Benjamin - - PowerPoint PPT Presentation

Malaria, medicines and miles: Investigating household access to malaria treatment Benjamin Palafox, GHD Malaria Centre Retreat March 2015 Background: Malaria treatment Recommended first-line treatment: Artemisinin-based combination


slide-1
SLIDE 1

Malaria, medicines and miles: Investigating household access to malaria treatment

Benjamin Palafox, GHD Malaria Centre Retreat March 2015

slide-2
SLIDE 2

Background:

Malaria treatment

  • Recommended first-line treatment:

– Artemisinin-based combination therapy (ACT) – Adopted by WHO in 2005 – Resistance to non-artemisinin therapy (e.g. SP) – Bans on oral artemisinin monotherapies

  • Large treatment gap persists

– Children with confirmed malaria who receive ACT ranges from 1% to 42%

slide-3
SLIDE 3

Background:

Conceptualising the ACT access gap

S U P P L Y D E M A N D S U P P L Y D E M A N D

slide-4
SLIDE 4

Presentation objectives

  • 1. Describe a method of combining supply- and demand-

side survey data to produce representative indicators

  • f household access to treatment
  • 2. Illustrate this approach to estimate supply-side access

indicators using data from Benin, Nigeria, Uganda and Zambia

  • 3. Discuss strengths and limitations of this approach and

implications for policy and practice

slide-5
SLIDE 5

Madagascar Benin Cambodia DRC Nigeria Uganda Zambia

Objective

Provide policy makers with evidence

  • n trends in availability, price, and

use of antimalarials

3 linked national surveys

Households, Outlets, Supply Chains

Methods:

The ACTwatch project

slide-6
SLIDE 6

Methods:

Household and outlet surveys

  • National cross-sectional

samples

  • 2 survey rounds per country:

2009-10 and 2011-12

  • Share similar multi-stage

cluster design

  • Included households: recently

febrile child under 5 years

  • Include outlets: all outlets

currently or recently stocking antimalarials

COUNTRY

slide-7
SLIDE 7
slide-8
SLIDE 8

Households:

  • Treatment choices for

febrile children under 5

  • Type, source, price paid

for treatment

  • Caregiver’s knowledge,

beliefs, attitudes

  • Household wealth index

based on assets and dwelling characteristics

  • Geographic coordinates

Outlets:

  • Availability, product details

and price of all antimalarials stocked

  • Provider perceptions and

knowledge of antimalarials

  • Availability and price of

diagnostic testing services

  • Geographic coordinates

Methods:

Household and outlet data

slide-9
SLIDE 9

Methods:

Creating the access dataset

  • Merge household and outlet datasets
  • Use geographic coordinates from households and outlets

in vicinity to define treatment options available

  • Defining treatment option ‘catchment area’

– By distance from household  different radii to define – By primary sampling unit

slide-10
SLIDE 10
  • Treatment options reasonably accessible to households:

– Radius of 5km around surveyed household – Number, types and other characteristics of treatment sources Types of antimalarials and diagnostics stocked and their prices

  • Basic supply-side indicators on availability

– % households with reasonable access to:

  • Any treatment source stocking ACT
  • Specific treatment source types stocking ACT
  • National estimates account for survey design

– Compared across urban and rural areas – Examine changes over time

Methods:

Defining access indicators

slide-11
SLIDE 11

% of households with access to ACTs vs. non-ACT within 5km

20 40 60 80 100 Base End Base End Base End Base End Base End Base End Base End Base End Urban Rural Urban Rural Urban Rural Urban Rural Benin Nigeria Uganda Zambia ACT Only non-ACT

slide-12
SLIDE 12

Public/Non-profit facility Private facility Pharmacy Drug store General retailer

% of rural households with access to ACT by source: over time

20 40 60 80 100 Benin Nigeria 20 40 60 80 100 Uganda Zambia

slide-13
SLIDE 13

Public/Non-profit facility Private facility Pharmacy Drug store General retailer

% of rural households with access to ACT by source: over time

20 40 60 80 100 Benin Nigeria 20 40 60 80 100 Uganda Zambia

slide-14
SLIDE 14

Other indicators and applications

  • Price of ACT and non-ACT accessible to households
  • Distance to nearest treatment sources
  • Quality: access to microscopy and RDTs, qualified health

professionals

  • Combined access dataset provides rich information from

supply and demand perspectives

– Integrated understanding of access and how to improve it – Enhance modelling determinants of treatment seeking behaviour

slide-15
SLIDE 15

Strengths

  • Produces objective, realistic,

dynamic and representative measures of access

  • Comparable across contexts

and over time: impact evaluations

  • Easily scaled and transferred

to other products/conditions

Limitations

  • Complementary surveys

must be conducted contemporaneously

  • Expensive: censusing
  • Simplistic use of geospatial

data

New approach to measure access

slide-16
SLIDE 16

www.actwatch.org

See our papers and reports here